CT patterns and serial CT Changes in lung Cancer patients post stereotactic body radiotherapy (SBRT)

被引:8
作者
Al-Umairi, Rashid [1 ]
Tarique, Usman [1 ]
Moineddin, Rahim [2 ]
Jimenez-Juan, Laura [3 ]
Kha, Lan Chau [1 ]
Cheung, Patrick [4 ]
Oikonomou, Anastasia [1 ]
机构
[1] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med Imaging, 2075 Bayview Ave, Toronto, ON M4N3M5, Canada
[2] Univ Toronto, Dalla Lana Sch Publ Hlth, Dept Family & Community Med, 500 Univ Ave, Toronto, ON M5G 1V7, Canada
[3] Univ Toronto, Dept Med Imaging, St Michaels Hosp,30 Bond St, Toronto, ON M5B 1W8, Canada
[4] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Radiat Oncol, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada
关键词
Computed tomography; Lung cancer; Stereotactic body radiotherapy; Radiation induced lung injury; CT patterns; RADIATION-THERAPY; ABLATIVE RADIOTHERAPY; FOLLOW-UP; INJURY; RECURRENCE; TUMORS; APPEARANCES; SABR;
D O I
10.1186/s40644-022-00491-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background To evaluate computed tomography (CT) patterns of post-SBRT lung injury in lung cancer and identify time points of serial CT changes. Materials and methods One hundred eighty-three tumors in 170 patients were evaluated on sequential CTs within 29 months (median). Frequencies of post-SBRT CT patterns and time points of initiation and duration were assessed. Duration of increase of primary lesion or surrounding injury without evidence of local recurrence and time to stabilization or local recurrence were evaluated. Results Post-SBRT CT patterns could overlap in the same patient and were nodule-like pattern (69%), consolidation with ground glass opacity (GGO) (41%), modified conventional pattern (39%), peribronchial/patchy consolidation (42%), patchy GGO (24%), diffuse consolidation (16%), "orbit sign" (21%), mass-like pattern (19%), scar-like pattern (15%) and diffuse GGO (3%). Patchy GGO started at 4 months post-SBRT. Peribronchial/patchy consolidation and consolidation with GGO started at 4 and 5 months respectively. Diffuse consolidation, diffuse GGO and orbit sign started at 5, 6 and 8 months respectively. Mass-like, modified conventional and scar-like pattern started at 8, 12 and 12 months respectively. Primary lesion (n = 11) or surrounding injury (n = 85) increased up to 13 months. Primary lesion (n = 119) or surrounding injury (n = 115) started to decrease at 4 and 9 months respectively. Time to stabilization was 20 months. The most common CT pattern at stabilization was modified conventional pattern (49%), scar-like pattern (23%) and mass-like pattern (12%). Local recurrence (n = 15) occurred at a median time of 18 months. Conclusion Different CT patterns of lung injury post-SBRT appear in predictable time points and have variable but predictable duration. Familiarity with these patterns and timeframes of appearance helps differentiate them from local recurrence.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Risk of radiation pneumonitis in patients with emphysema after stereotactic body radiotherapy for non-small cell lung cancer assessed by quantitative CT
    Uchiyama, Fumiya
    Nakayama, Hidetsugu
    Takeda, Yuichiro
    Wang, Wenjie
    Minamimoto, Ryogo
    Tajima, Tsuyosi
    MOLECULAR AND CLINICAL ONCOLOGY, 2020, 13 (03) : 1 - 6
  • [32] Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer
    Gkika, E.
    Adebahr, S.
    Kirste, S.
    Schimek-Jasch, T.
    Wiehle, R.
    Claus, R.
    Wittel, U.
    Nestle, U.
    Baltas, D.
    Grosu, A. L.
    Brunner, T. B.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 (06) : 433 - 443
  • [33] Stereotactic Body Radiotherapy (SBRT) Is as Yet of Unproven Benefit for Patients With Lung Metastases
    Treasure, Tom
    Macbeth, Fergus
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (04): : 423 - 424
  • [34] Clinical utility of texture analysis of 18F-FDG PET/CT in patients with Stage I lung cancer treated with stereotactic body radiotherapy
    Takeda, Kazuya
    Takanami, Kentaro
    Shirata, Yuko
    Yamamoto, Takaya
    Takahashi, Noriyoshi
    Ito, Kengo
    Takase, Kei
    Jingu, Keiichi
    JOURNAL OF RADIATION RESEARCH, 2017, 58 (06) : 862 - 869
  • [35] Stereotactic body radiotherapy (SBRT) and concomitant systemic therapy in oligoprogressive breast cancer patients
    Luca Nicosia
    Vanessa Figlia
    Nicola Ricottone
    Francesco Cuccia
    Rosario Mazzola
    Niccolò Giaj-Levra
    Francesco Ricchetti
    Michele Rigo
    Fatemeh Jafari
    Stefano Maria Magrini
    Andrea Girlando
    Filippo Alongi
    Clinical & Experimental Metastasis, 2022, 39 : 581 - 588
  • [36] FRAMELESS STEREOTACTIC BODY RADIOTHERAPY FOR LUNG CANCER USING FOUR-DIMENSIONAL CONE BEAM CT GUIDANCE
    Sonke, Jan-Jakob
    Rossi, Maddalena
    Wolthaus, Jochem
    van Herk, Marcel
    Damen, Eugene
    Belderbos, Jose
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (02): : 567 - 574
  • [37] Is stereotactic body radiotherapy an alternative to surgery in early stage non small cell lung cancer?
    Yaprak, Gokhan
    Seseogullari, Ozgur Ozan
    Akaslan, Bedriye Dogan
    Isik, Naciye
    JOURNAL OF BUON, 2019, 24 (04): : 1619 - 1625
  • [38] Comprehensive Analysis of Pulmonary Function Test (PFT) Changes After Stereotactic Body Radiotherapy (SBRT) for Stage I Lung Cancer in Medically Inoperable Patients
    Stephans, Kevin L.
    Djemil, Toufik
    Reddy, Chandana A.
    Gajdos, Stephen M.
    Kolar, Mathew
    Machuzak, Michael
    Mazzone, Peter
    Videtic, Gregory M. M.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (07) : 838 - 844
  • [39] Stereotactic body radiotherapy in patients with multiple lung tumors: a focus on lung dosimetric constraints
    Milano, Michael T.
    Mihai, Alina
    Kang, John
    Singh, Deepinder P.
    Verma, Vivek
    Qiu, Haoming
    Chen, Yuhchyau
    Kong, Feng-Ming
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (11) : 959 - 969
  • [40] Stereotactic Body Radiotherapy (SBRT) in Very Limited-Stage Small Cell Lung Cancer (VLS-SCLC)
    Mercier, Stephanie L.
    Moore, Sara M.
    Akurang, Deborah
    Tiberi, David
    Wheatley-Price, Paul
    CURRENT ONCOLOGY, 2023, 30 (01) : 100 - 109